Alcohol Use Disorder

Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder

In Hospital IM Naltrexone: A Pilot Study

Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms

Alcohol Use Disorder and Cannabidiol

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder

Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use

Cannabidiol and Alcohol Use Disorder Phenotypes

Study of Sunobinop on Craving in Alcohol Use Disorder

Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder

Motivation for IV Alcohol Self-Administration in Humans

Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

Human Laboratory Study of ASP8062 for Alcohol Use Disorder

MAP4343 Treatment for Alcohol Use Disorder

CBD for the Treatment of Alcohol Use Disorder

COMT Inhibition Among Individuals With Comorbid AUD/ADHD

Brexpiprazole in Alcohol Use Disorder

Development of a Selective ALDH2 Inhibitor to Treat AUD

Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects

Ibudilast for the Treatment of Alcohol Use Disorder

Ibudilast and Withdrawal-Related Dysphoria

A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder

Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders

Naltrexone for Individuals of East Asian Descent

Harm Reduction With Pharmacotherapy (HaRP)

Development of Ivermectin for Alcohol Use Disorders

Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder

Enhancing the Effects of Alcohol Treatment With L-Carnitine

A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine

Phase 1b Study of DCR-AUD in Healthy Volunteers

A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol

tAN for Substance Use Disorder

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)

Evaluating a One-Year Version of the Parent-Child Assistance Program

Effect of Social Isolation on the Role of Pavlovian Mechanisms for Control Over Alcohol Use

CM for Patients With ALD After Liver Transplant

Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

Alcoholic Liver Disease and the Gut Microbiome

Alcohol and Cannabis Concentrates Co-Administration

Cannabidiol Effects on Blood Alcohol Level and Intoxication

Facilitating Alcohol Screening and Treatment (FAST)

Virtual Reality Alcohol Avoidance Training

A Study of the Effectiveness of Direct Current Stimulation for Alcohol Use Disorders

A Study of New Treatment for Excessive Alcohol Users by Electric Stimulation of Nerves Around Ear

Pilot Evaluation of the Empower Neuromodulation System in AUD Patients

Treatment Parameters for the Empower Neuromodulation System (ENS)

Treatment for Comorbid Social Anxiety and Alcohol Use Disorders.

Mental Contrasting With Implementation Intentions for Alcohol Use Disorders

Considering Healthier Drinking Options in Collaborative Care